Does smoking reduction increase future cessation and decrease disease risk? A qualitative review.

This review examines whether reduction in smoking among smokers not currently interested in quitting (a) undermines or promotes future smoking cessation or (b) decreases the risks of developing smoking-related diseases. Systematic computer searches and other methods located 19 studies examining reduction and subsequent cessation and 10 studies examining reduction and disease risk. Because of the heterogeneity of methods and results, a meta-analysis could not be undertaken. None of 19 studies found that reduction undermined future cessation, and 16 found that reduction was associated with greater future cessation, including the two randomized trials of reduction versus nonreduction. The 10 trials of disease risk found conflicting results, and none was an adequate test. We conclude that (a) smoking reduction increases the probability of future cessation and (b) whether smoking reduction decreases the risks of smoking-related diseases has not been adequately tested.

[1]  G. Giovino,et al.  Reducing tobacco harm: research challenges and issues. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[2]  T. Pechacek,et al.  How acute and reversible are the cardiovascular risks of secondhand smoke? , 2004, BMJ : British Medical Journal.

[3]  B. Jamerson,et al.  Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. , 2004, The American journal of medicine.

[4]  J. Hughes,et al.  The feasibility of smoking reduction: an update. , 2005, Addiction.

[5]  S. Shiffman,et al.  Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth. , 2000, Drug and alcohol dependence.

[6]  K. Cummings,et al.  Reduction in amount smoked predicts future cessation. , 2005, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[7]  R. Glasgow,et al.  Controlled smoking versus abstinence as a treatment goal: The hopes and fears may be unfounded , 1989 .

[8]  E. Levin,et al.  Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone , 1994, Clinical pharmacology and therapeutics.

[9]  P. Tønnesen Smoking Reduction for Smokers Not Able or Motivated to Quit? , 2002, Respiration.

[10]  K. Warner Tobacco harm reduction: promise and perils. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[11]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[12]  J. Meador-Woodruff,et al.  Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  A Dijkstra,et al.  Subtypes of precontemplating smokers defined by different long-term plans to change their smoking behavior. , 2000, Health education research.

[14]  P. Boyle,et al.  Characteristics of smokers' attitudes towards stopping: survey of 10,295 smokers in representative samples from 17 European countries , 2000 .

[15]  J. Connett,et al.  Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study , 2005, European Respiratory Journal.

[16]  D. Hatsukami,et al.  Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  R. Foxx,et al.  Nicotine's role in smoking: an analysis of nicotine regulation. , 1983, Psychological bulletin.

[18]  A. Farkas,et al.  Tobacco Use in California: An Evaluation of the Tobacco Control Program, 1989-1993. A Report to the California Department of Health Services , 1994 .

[19]  J. Hughes,et al.  Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. , 2004, Journal of consulting and clinical psychology.

[20]  A. Auquier,et al.  Changes in patterns of cigarette smoking and lung cancer risk: results of a case-control study. , 1989, British Journal of Cancer.

[21]  T. George,et al.  A placebo controlled trial of bupropion for smoking cessation in schizophrenia , 2002, Biological Psychiatry.

[22]  J. Connett,et al.  Smoking reduction in the Lung Health Study. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[23]  L. Kozlowski,et al.  Influence of Smoking Fewer Cigarettes on Exposure to Tar, Nicotine, and Carbon Monoxide , 1987 .

[24]  A. Bandura Self-efficacy: toward a unifying theory of behavioral change. , 1977, Psychological review.

[25]  Å. Westin,et al.  Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety , 2000, BMJ : British Medical Journal.

[26]  S. Shiffman,et al.  Measuring nicotine dependence among youth: a review of available approaches and instruments. , 2000, Drug and alcohol dependence.

[27]  Douglas G. Altman,et al.  Systematic Reviews in Health Care: Meta-Analysis in Context: Second Edition , 2008 .

[28]  P. Schnohr,et al.  Effects of smoking and changes in smoking habits on the decline of FEV1. , 1989, The European respiratory journal.

[29]  J. Vestbo,et al.  Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study , 2002, Thorax.

[30]  K. Fagerström Can Reduced Smoking Be a Way for Smokers Not Interested in Quitting to Actually Quit? , 2005, Respiration.

[31]  Robert Rosenthal,et al.  WRITING META-ANALYTIC REVIEWS , 1995 .

[32]  J. Mann,et al.  Intermittent claudication: factors determining outcome. , 1978, British medical journal.

[33]  David Satcher,et al.  Women and smoking: a report of the Surgeon General. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[34]  Y I Hser,et al.  Individual change amid stable smoking patterns in polydrug users over 3 years. , 2001, Addictive behaviors.

[35]  R. Wallace,et al.  Clearing the smoke: assessing the science base for tobacco harm reduction. , 2001 .

[36]  B. B. Ross,et al.  The effect of smoking cessation and modification on lung function. , 1976, The American review of respiratory disease.

[37]  Å. Westin,et al.  Effects of smoking cessation and reduction in asthmatics. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[38]  P. Shields Tobacco smoking, harm reduction, and biomarkers. , 2002, Journal of the National Cancer Institute.

[39]  D. Hatsukami,et al.  Harm reduction approaches to reducing tobacco-related mortality. , 2004, Annual review of public health.

[40]  K. Fagerström,et al.  Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. , 1995, Chest.

[41]  Jean-François Etter,et al.  Impact of messages on concomitant use of nicotine replacement therapy and cigarettes: a randomized trial on the Internet. , 2003, Addiction.

[42]  A. Tverdal,et al.  Health consequences of smoking 1–4 cigarettes per day , 2005, Tobacco Control.

[43]  J. Vestbo,et al.  Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976–1998: a pooled cohort study , 2003, Journal of epidemiology and community health.

[44]  M. Stein,et al.  Respiratory symptom relief related to reduction in cigarette use , 2005, Journal of General Internal Medicine.

[45]  Å. Westin,et al.  Smoking reduction treatment with 4‐mg nicotine gum: A double‐blind, randomized, placebo‐controlled study , 2005, Clinical pharmacology and therapeutics.

[46]  J. Vestbo,et al.  Smoking reduction, smoking cessation, and mortality: a 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. , 2002, American journal of epidemiology.

[47]  M. Egger,et al.  The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.

[48]  D. Mackinnon,et al.  Mediation designs for tobacco prevention research. , 2002, Drug and alcohol dependence.

[49]  A. Joseph,et al.  Predictors of smoking reduction without formal intervention. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[50]  A. Møller,et al.  Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial , 2002, The Lancet.

[51]  Å. Westin,et al.  Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. , 2003, Addiction.

[52]  L. Mosca,et al.  Preoperative smoking habits and postoperative pulmonary complications. , 1998, Chest.

[53]  M. Jofre-Bonet,et al.  Reduction of quantity smoked predicts future cessation among older smokers. , 2004, Addiction.

[54]  A. Farkas When does cigarette fading increase the likelihood of future cessation? , 1999, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[55]  M. Lindström,et al.  Long term and transitional intermittent smokers: a longitudinal study , 2002, Tobacco control.

[56]  Office on Smoking The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[57]  J. Lubin,et al.  Modifying risk of developing lung cancer by changing habits of cigarette smoking. , 1984, British medical journal.

[58]  Emil H Schemitsch,et al.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[59]  K. Cummings,et al.  Ability of smokers to reduce their smoking and its association with future smoking cessation. , 1999, Addiction.

[60]  A. Diacon,et al.  Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. , 2004, Addiction.

[61]  W. McIlroy,et al.  Should unpublished data be included in meta-analyses? Current convictions and controversies. , 1993, JAMA.

[62]  G. Swan The need for dissemination of evidence-based results from research on nicotine and tobacco. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[63]  T. Jørgensen,et al.  Smoking reduction intervention in a large population-based study. The Inter99 study. , 2005, Preventive medicine.

[64]  Å. Westin,et al.  Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[65]  Merete Osler,et al.  Effect of smoking reduction on lung cancer risk. , 2005, JAMA.

[66]  T. Perneger,et al.  Postintervention Effect of Nicotine Replacement Therapy on Smoking Reduction in Smokers Who Are Unwilling to Quit: Randomized Trial , 2004, Journal of clinical psychopharmacology.

[67]  R. Wallace,et al.  Clearing the Smoke , 2001 .

[68]  P. Cinciripini,et al.  The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? , 1995, Journal of consulting and clinical psychology.

[69]  G. Scherer Smoking behaviour and compensation: a review of the literature , 1999, Psychopharmacology.

[70]  J. Hughes Reduced smoking: an introduction and review of the evidence. , 2000, Addiction.

[71]  M. Susser The tribulations of trials--intervention in communities. , 1995, American journal of public health.

[72]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[73]  J. Koplan,et al.  Preventing tobacco use among young people. A report of the Surgeon General. Executive summary. , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[74]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[75]  Robyn L Richmond,et al.  Measures of abstinence in clinical trials: issues and recommendations. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[76]  D. Wetter,et al.  Prevalence and predictors of transitions in smoking behavior among college students. , 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[77]  R. Buchanan,et al.  Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. , 2001, The American journal of psychiatry.

[78]  Josue P. Keely,et al.  Effect of smoking reduction on later cessation: a pilot experimental study. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[79]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[80]  H. Rumpf,et al.  Intentionally reduced smoking among untreated general population smokers: prevalence, stability, prediction of smoking behaviour change and differences between subjects choosing either reduction or abstinence. , 2003, Addiction.

[81]  S. Shiffman,et al.  Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[82]  C. Husten,et al.  Cigarette smoking among adults--United States, 2002. , 2004, MMWR. Morbidity and mortality weekly report.

[83]  R. Jeffery,et al.  Occasional smoking in a Minnesota working population. , 1996, American journal of public health.